(MQ) on Tuesday reported second-quarter net income of $7.6 million. On a per-share basis, the Oakland, California-based company said it had net income of 7 cents. The results beat Wall Street expectations.
The average estimate of four analysts surveyed by Zacks Investment Research was breakeven on a per-share basis. The transaction processing services provider posted revenue of $176 million in the period, also beating Street forecasts. Four analysts surveyed by Zacks expected $172.9 million.
_____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MQ at https://www.zacks.com/ap/MQ Source (WEYS) on Tuesday reported net income of $13.3 million in its second quarter.
The Glendale, Wisconsin-based company said it had profit of $1.39 per share. The footwear distributor posted revenue of $62.2 million in the period. Access a Zacks stock report on WEYS at https://www.zacks.com/ap/WEYS Source
(AP) — Ultragenyx Pharmaceutical Inc. (RARE) on Tuesday reported a loss of $92 million in its second quarter. On a per-share basis, the Novato, California-based company said it had a loss of 90 cents.
The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of $1.27 per share. The biotechnology company posted revenue of $214 million in the period, also exceeding Street forecasts. Five analysts surveyed by Zacks expected $181 million.
Summary from source